The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
Hsiou, Y., Ding, J., Das, K., Clark Jr., A.D., Boyer, P.L., Lewi, P., Janssen, P.A., Kleim, J.P., Rosner, M., Hughes, S.H., Arnold, E.(2001) J Mol Biol 309: 437-445
- PubMed: 11371163 
- DOI: 10.1006/jmbi.2001.4648
- Primary Citation of Related Structures:  
1HPZ, 1HQE, 1HQU - PubMed Abstract: 
Inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT) are widely used in the treatment of HIV infection. Loviride (an alpha-APA derivative) and HBY 097 (a quinoxaline derivative) are two potent non-nucleoside RT inhibitors (NNRTIs) that have been used in human clinical trials ...